Novartis OTC Habitrol Taking Private Label Tack
This article was originally published in The Tan Sheet
Novartis Consumer Health is planning a "major" private label initiative with its newly approved OTC nicotine patches involving Wal-Mart, CVS and Walgreens. The firm intends to later market the product under its original Habitrol name, but the initial focus is in the private label setting. OTC Habitrol was approved Nov. 12.
You may also be interested in...
Geneva Pharmaceuticals initially will market the first generic competition to Schering-Plough's OTC Claritin behind pharmacy counters
Novartis Consumer Healthcare's Habitrol multi-dose smoking cessation kit will represent the first time an entire course of nicotine replacement therapy is available in a single package
Requiring a special California Proposition 65 pregnancy warning on OTC nicotine-containing smoking cessation patches and gums would conflict with FDA requirements, a San Francisco state court judge has ruled.